This is a Phase 3, Two-part (Open-label Followed by Randomized Double-masked Active Controlled) Study to Compare the Efficacy and Safety of HLX04-O (VEGF) Administered by Intravitreal Injection with active comparator Ranibizumab in Subjects with wet Age-related Macular Degeneration (wAMD).
ClinicalTrials.gov Identifier: NCT04740671
Principal Investigator: Dr Chandra Balaratnasingam
For further information about this study, you may visit the Clinical Trials Registry or contact the Lions Eye Institute Clinical Trials Office on (08) 9381 0750 or clinicalresearch@lei.org.au.
